Article Sidebar

PDF
Date Published: 23/09/2022
Abstract Views: 242
Views PDF: 107
DOI: https://doi.org/10.51298/vmj.v518i1.3347
Issue
Vol. 518 No. 1 (2022)
Section
Các bài báo
How to Cite
Thu Trang, N. ., & Anh Tú, Đỗ . (2022). RESULTS OF CHEMICALS OF PACLITAXEL AND CARBOPLATIN REGULATIONS IN STAGE IV ESOPHAGEAL CANCER PATIENTS AT K HOSPITAL. Vietnam Medical Journal, 518(1). https://doi.org/10.51298/vmj.v518i1.3347

RESULTS OF CHEMICALS OF PACLITAXEL AND CARBOPLATIN REGULATIONS IN STAGE IV ESOPHAGEAL CANCER PATIENTS AT K HOSPITAL

Nguyễn Thu Trang1,, Đỗ Anh Tú1
1 Vietnam National Cancer Hospital

Main Article Content

Abstract

Objective: Evaluate the results of paclitaxel and carboplatin chemotherapy regimens in patients with stage IV esophageal cancer at K hospital. Methods: A retrospective and prospective descriptive study were conducted on 48 patients with stage IV esophageal cancer during the period from August 2021 to August 2022. Results: The rate of patients responding to treatment after 3 was 43.8% (partial response was 37.5% and the total response was 6.3%). The rate of patients responding to treatment after 6 was 52.1% (partial response was 43.8% and total response was 8.3%). Common symptoms of choking, pain when swallowing, aspiration improved. Undesirable effects including nausea, vomiting, stomatitis, diarrhea, hair loss tend to decrease over the course of treatment cycles. Hematologic toxicity is low and controllable. Conclusion: This treatment regimen may be more commonly applied in the treatment of esophageal cancer due to its safety and good tolerability.

Article Details

Keywords

Chemotherapy, Esophageal Cancer, Paclitaxel and Carboplatin

References

1. International Agency for Research on Cancer, Oesophagus - Global Cancer Observatory. 2020.
2. Sung, H., et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 2021. 71(3): p. 209-249.
3. International Agency for Research on Cancer, VietNam - Global Cancer Observatory. 2020.
4. Keresztes, R.S., et al., Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial. The Journal of Thoracic and Cardiovascular Surgery, 2003. 126(5): p. 1603-1608.
5. de Man, F.M., et al., Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients. Cancers (Basel), 2019. 11(6).
6. Wang, H., et al., A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol, 2007. 2(2): p. 153-7.
7. Nguyễn Đức Lợi, Đánh giá hiệu quả của hóa xạ trị gia tốc đồng thời trong điều trị ung thư thực quản giai đoạn III, IV bệnh viện K. Tạp chí Y học Việt Nam, 2018. 471(Số chuyên đề ung thư): tr. 48-55.
8. Noronha, V., et al., Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer. Oncol Res, 2016. 23(4): p. 183-95.
9. Ter Veer, E., et al., The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis. J Natl Cancer Inst, 2016. 108(10).
10. Joseph, D.M., et al., Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study. South Asian J Cancer, 2021. 10(3): p. 151-154.